The latest deal builds on an existing collaboration between the two companies to develop ADC programmes for solid tumours. Credit: Gorodenkoff/Shutterstock. Samsung Biologics has extended
The funding will enable Aspect to propel multiple bioprinted tissue therapeutic projects toward clinical trials. Credit: luchschenF/Shutterstock. Aspect Biosystems has secured $115m in a Series
Under the agreement, Mankind Pharma will have the exclusive rights to register, import, market, sell, and distribute Sintilimab in India. Credit: Piotr Swat/Shutterstock. Mankind Pharma
Datopotamab deruxtecan is intended for use in adults with locally advanced or metastatic nonsquamous NSCLC. Credit: New Africa/Shutterstock. AstraZeneca and Daiichi Sankyo have withdrawn their
The company will focus on creating small molecule therapeutics that enhance the natural function of proteasomes. Credit: Gorodenkoff/Shutterstock. Booster Therapeutics has announced its inception, backed
Lilly will gain worldwide rights for the development and commercialisation of DACRA molecules to treat obesity. Credit: New Africa/Shutterstock. Nordic Bioscience subsidiary KeyBioscience has announced
Merck’s new €290m biosafety testing facility in Rockville features advanced testing capabilities. Credit: Merck/Business Wire. Germany-based Merck KGaA has announced the launch of a new
The company’s single-cell-based discovery engine can detect the specific pathogenic cells that cause disease, and their surface markers. Credit: PeopleImages.com – Yuri A/Shutterstock. Arda Therapeutics
Boehringer Ingelheim focuses on targeting the proteins involved in this process as a promising strategy for developing new cancer treatments. Credit: Tada Images/Shutterstock. Boehringer Ingelheim
The company had sought approval for dasiglucagon for the treatment and prevention of hypoglycaemia in infants with congenital hyperinsulinism. Credit: Gorodenkoff/Shutterstock. The US Food and